⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Official Title: An Open-Label, Phase 2 Study to Evaluate the Efficacy and Tolerability of ABT-869 in Subjects With Advanced Renal Cell Carcinoma (RCC) Who Have Previously Received Treatment With Sunitinib

Study ID: NCT00486538

Interventions

ABT-869

Study Description

Brief Summary: This study is designed to determine the clinical efficacy and toxicity of ABT 869 in the treatment of subjects with advanced renal cell carcinoma who have previously received treatment with sunitinib.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Site Reference ID/Investigator# 7193, Sacramento, California, United States

Site Reference ID/Investigator# 5243, Washington, District of Columbia, United States

Site Reference ID/Investigator# 5384, Chicago, Illinois, United States

Site Reference ID/Investigator# 11662, Boston, Massachusetts, United States

Site Reference ID/Investigator# 11663, Boston, Massachusetts, United States

Site Reference ID/Investigator# 5379, Boston, Massachusetts, United States

Site Reference ID/Investigator# 5380, Lebanon, New Hampshire, United States

Site Reference ID/Investigator# 5249, Philadelphia, Pennsylvania, United States

Site Reference ID/Investigator# 6278, Philadelphia, Pennsylvania, United States

Site Reference ID/Investigator# 6269, Pittsburgh, Pennsylvania, United States

Site Reference ID/Investigator# 7300, Charleston, South Carolina, United States

Site Reference ID/Investigator# 6796, Houston, Texas, United States

Site Reference ID/Investigator# 6566, Vancouver, , Canada

Contact Details

Name: Justin L. Ricker, MD

Affiliation: AbbVie

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: